156
Participants
Start Date
September 30, 2007
Primary Completion Date
September 30, 2012
Study Completion Date
January 31, 2016
rituximab
375 mg/m2 i.v. per cycle
cyclophosphamide
750 mg/m2 i.v. per cycle
doxorubicin hydrochloride
50 mg/m2 i.v. per cycle
prednisone
100 mg/day p.o. per cycle
vincristine sulfate
1.4 mg/m2 (max. 2.0 mg) i.v. per cycle
positron emission tomography
PET Scan during treatment
Regionalspital, Thun
European Institute of Oncology, Milan
Hirslanden Klinik Aarau, Aarau
Kantonspital Aarau, Aarau
Kantonsspital Baden, Baden
Praxis Dr. Streit, Baden
Saint Claraspital AG, Basel
Universitaetsspital-Basel, Basel
Oncology Institute of Southern Switzerland, Bellinzona
Inselspital Bern, Bern
Kantonsspital Bruderholz, Bruderholz
Kantonsspital Graubuenden, Chur
Hopital Cantonal Universitaire de Geneve, Geneva
Kantonsspital Liestal, Liestal
Kantonsspital Olten, Olten
Praxis Dr. Beretta, Rheinfelden
Kantonsspital - St. Gallen, Sankt Gallen
Kantonsspital Winterthur, Winterthur
UniversitaetsSpital Zuerich, Zurich
Swiss Cancer Institute
OTHER